A quick strengths, weaknesses, opportunities and threats following Becton Dickinson's earning report last week.
BDX is a boring stock and I happen to like boring stocks. Slow growth, dividend goes up every year, there's always demand for healthcare. The stock price has been bid up along with most dividend payers in the scramble for yield. Valuation isn't great, but still fair at about 17 times guidance provided with last week's earnings report.
Disclosure: Long BDX and plan on adding another small dose once the two-day 'no trade' window around my article opens.